Hob Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021
April 21, 2021 at 09:03 am
Share
HOB Biotech Group Corp.,Ltd announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 60.990 million compared to CNY 20.366 million a year ago. Operating income was CNY 14.534 million compared to operating loss of CNY 6.588 million a year ago. Net income was CNY 13.336 million compared to net loss of CNY 5.333 million a year ago. Basic earnings per share from continuing operations was CNY 0.23 compared to basic loss per share from continuing operations of CNY 0.11 a year ago.
HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others. The Company conducts its businesses in the domestic market.
HOB BIOTECH GROUP CORP.,LTD 